Captrust Financial Advisors Shockwave Medical, Inc. Transaction History

Captrust Financial Advisors

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $59,464 - $86,894	306 Added 36.87%	1,136 $226,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $185,131 - $251,224	830 New	830 $236,000
Q2 2022 Aug 23, 2022	SELL	$115.91 - $214.48 $14,372 - $26,595	-124 Reduced 8.56%	1,324 $253,000
Q2 2022 Aug 16, 2022	BUY	$115.91 - $214.48 $29,209 - $54,048	252 Added 21.07%	1,448 $277,000
Q1 2022 May 16, 2022	BUY	$127.96 - $207.36 $115,419 - $187,038	902 Added 306.8%	1,196 $248,000
Q4 2021 Feb 14, 2022	SELL	$165.13 - $241.83 $3,302 - $4,836	-20 Reduced 6.37%	294 $52,000
Q3 2021 Nov 16, 2021	BUY	$163.99 - $235.57 $1,147 - $1,648	7 Added 2.28%	314 $65,000
Q2 2021 Aug 16, 2021	SELL	$131.45 - $201.49 $43,509 - $66,693	-331 Reduced 51.88%	307 $58,000
Q1 2021 May 17, 2021	BUY	$92.73 - $142.05 $59,161 - $90,627	638 New	638 $83,000
Q3 2020 Nov 17, 2020	SELL	$42.79 - $75.8 $4,279 - $7,580	-100 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.25 - $47.53 $2,725 - $4,753	100 New	100 $5,000
Q4 2019 Feb 14, 2020	SELL	$29.4 - $44.98 $7,350 - $11,245	-250 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$29.73 - $66.02 $7,432 - $16,505	250 New	250 $14,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.